Cargando…

Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?

BACKGROUND: We studied the association between (1) the retinal thickness, volume and structure assessed by optical coherence tomography (OCT), and (2) vascular changes around the fovea in FA to define the role of these methods in the detection of ischemic diabetic maculopathy. METHODS: This retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dmuchowska, Diana Anna, Krasnicki, Pawel, Mariak, Zofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007050/
https://www.ncbi.nlm.nih.gov/pubmed/24292702
http://dx.doi.org/10.1007/s00417-013-2518-x
_version_ 1782314300890677248
author Dmuchowska, Diana Anna
Krasnicki, Pawel
Mariak, Zofia
author_facet Dmuchowska, Diana Anna
Krasnicki, Pawel
Mariak, Zofia
author_sort Dmuchowska, Diana Anna
collection PubMed
description BACKGROUND: We studied the association between (1) the retinal thickness, volume and structure assessed by optical coherence tomography (OCT), and (2) vascular changes around the fovea in FA to define the role of these methods in the detection of ischemic diabetic maculopathy. METHODS: This retrospective observational study included 51 eyes of 51 patients with severe non-proliferative and proliferative diabetic retinopathy, considering that they present advanced ischemic retinal changes. Based on the clinical examination and presence of leakage on FA, patients with clinically significant macular edema were excluded. On FA, foveal avascular zone (FAZ) corresponds to capillary loss and reflects ischemic processes. Its outline and size were assessed according to the ETDRS standards. Patients were divided in two groups according to the severity of damage of the FAZ outline: ≤ grade 2 (n = 28) and ≥ grade 3 (n = 23). As we expected ischemia-related damage, SD-OCT images were evaluated for retinal structure, volume, total thickness with division into the outer and inner retina (to assess the influence of two, non-overlapping blood sources) and ganglion cell layer thickness. RESULTS: The comparisons revealed that at least currently with described methods: 1. There is no significant association between FAZ outline and retinal volume, total thickness, and thickness of the outer and inner retina and ganglion cell layer. 2. There is no significant association between FAZ outline and following retinal structure characteristics: continuity of the external limiting membrane and inner segment/outer segment junction, and identification of the inner/outer retina boundary. 3. The identification of ganglion cell layer boundaries was significantly more difficult in more advanced FAZ outline grades. 4. FAZ size is not correlated with the retinal thickness and volume. CONCLUSIONS: In patients with severe non-proliferative and proliferative diabetic retinopathy, it is not possible to predict FAZ outline/size based solely on the measurements assessing volume and thickness or retinal structure evaluation on OCT. Consequently, at present OCT cannot replace FA in the detection of ischemic diabetic maculopathy.
format Online
Article
Text
id pubmed-4007050
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-40070502014-05-07 Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy? Dmuchowska, Diana Anna Krasnicki, Pawel Mariak, Zofia Graefes Arch Clin Exp Ophthalmol Retinal Disorders BACKGROUND: We studied the association between (1) the retinal thickness, volume and structure assessed by optical coherence tomography (OCT), and (2) vascular changes around the fovea in FA to define the role of these methods in the detection of ischemic diabetic maculopathy. METHODS: This retrospective observational study included 51 eyes of 51 patients with severe non-proliferative and proliferative diabetic retinopathy, considering that they present advanced ischemic retinal changes. Based on the clinical examination and presence of leakage on FA, patients with clinically significant macular edema were excluded. On FA, foveal avascular zone (FAZ) corresponds to capillary loss and reflects ischemic processes. Its outline and size were assessed according to the ETDRS standards. Patients were divided in two groups according to the severity of damage of the FAZ outline: ≤ grade 2 (n = 28) and ≥ grade 3 (n = 23). As we expected ischemia-related damage, SD-OCT images were evaluated for retinal structure, volume, total thickness with division into the outer and inner retina (to assess the influence of two, non-overlapping blood sources) and ganglion cell layer thickness. RESULTS: The comparisons revealed that at least currently with described methods: 1. There is no significant association between FAZ outline and retinal volume, total thickness, and thickness of the outer and inner retina and ganglion cell layer. 2. There is no significant association between FAZ outline and following retinal structure characteristics: continuity of the external limiting membrane and inner segment/outer segment junction, and identification of the inner/outer retina boundary. 3. The identification of ganglion cell layer boundaries was significantly more difficult in more advanced FAZ outline grades. 4. FAZ size is not correlated with the retinal thickness and volume. CONCLUSIONS: In patients with severe non-proliferative and proliferative diabetic retinopathy, it is not possible to predict FAZ outline/size based solely on the measurements assessing volume and thickness or retinal structure evaluation on OCT. Consequently, at present OCT cannot replace FA in the detection of ischemic diabetic maculopathy. Springer Berlin Heidelberg 2013-11-29 2014 /pmc/articles/PMC4007050/ /pubmed/24292702 http://dx.doi.org/10.1007/s00417-013-2518-x Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Retinal Disorders
Dmuchowska, Diana Anna
Krasnicki, Pawel
Mariak, Zofia
Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
title Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
title_full Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
title_fullStr Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
title_full_unstemmed Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
title_short Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
title_sort can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
topic Retinal Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007050/
https://www.ncbi.nlm.nih.gov/pubmed/24292702
http://dx.doi.org/10.1007/s00417-013-2518-x
work_keys_str_mv AT dmuchowskadianaanna canopticalcoherencetomographyreplacefluoresceinangiographyindetectionofischemicdiabeticmaculopathy
AT krasnickipawel canopticalcoherencetomographyreplacefluoresceinangiographyindetectionofischemicdiabeticmaculopathy
AT mariakzofia canopticalcoherencetomographyreplacefluoresceinangiographyindetectionofischemicdiabeticmaculopathy